A detailed history of Norwood Financial Corp transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Norwood Financial Corp holds 385 shares of DGX stock, worth $52,779. This represents 0.07% of its overall portfolio holdings.

Number of Shares
385
Previous 385 -0.0%
Holding current value
$52,779
Previous $53,000 3.77%
% of portfolio
0.07%
Previous 0.08%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 11, 2024

SELL
$120.62 - $141.12 $6,031 - $7,056
-50 Reduced 11.49%
385 $53,000
Q1 2022

Apr 25, 2022

BUY
$129.09 - $164.35 $20,654 - $26,296
160 Added 58.18%
435 $60,000
Q4 2021

Feb 08, 2022

BUY
$140.36 - $173.01 $38,599 - $47,577
275 New
275 $48,000

Others Institutions Holding DGX

About QUEST DIAGNOSTICS INC


  • Ticker DGX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 113,887,000
  • Market Cap $15.6B
  • Description
  • Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...
More about DGX
Track This Portfolio

Track Norwood Financial Corp Portfolio

Follow Norwood Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norwood Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Norwood Financial Corp with notifications on news.